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Introduction {#s1}
============

Air pollution is a major concern in public health. Long-term air pollution exposure has been consistently associated with lower function in adults ([@c1]; [@c2]; [@c22]), children ([@c6]; [@c24]; [@c60]) and in those with preexisting lung disease ([@c44]). In the LifeLines cohort study, a large representative sample of the north of Netherlands, a higher level of nitrogen dioxide ($\text{NO}_{2}$) and particulate matter (PM) exposure was associated with lower forced expiratory volume in 1 s ($\text{FEV}_{1}$) and even lower forced vital capacity (FVC), and as a consequence, a higher $\text{FEV}_{1}/\text{FVC}$ ratio ([@c18]).

Activation of oxidant and pro-inflammatory pathways is suggested to be a potential mechanism underlying the acute toxicity of $\text{NO}_{2}$ and PM ([@c39]), yet the knowledge on exact mechanisms underlying the effect of long-term air pollution exposure on health is inconclusive. Although clear evidence exists for the association between genetics and lung function ([@c28]), the genetic background cannot entirely explain the phenotypic variability. Emerging evidence suggests that apart from specific genetic variants, epigenetic alterations in response to environmental exposure is an important determinant of respiratory health ([@c12]). DNA methylation, currently the most frequently studied epigenetic mechanism, occurs by the binding of a methyl group to a cytosine-guanine dinucleotide (CpG site) ([@c25]). Changes in DNA methylation may be induced by exposure to air pollution and may alter the gene expression profile. This change in DNA methylation is one plausible mechanism potentially mediating the adverse health effects of air pollution ([@c29]). Differential blood DNA methylation in response to air pollution exposure has been reported in environmental ([@c11]; [@c19]), occupational ([@c54]; [@c58]), and experimental settings ([@c20]). The strongest epigenetic signals identified in response to air pollution exposure were found in candidate genes for inflammatory pathways (*F3, ICAM-1, TLR-2*, $IFN - \gamma$*, IL-6*) ([@c11]), detoxification metabolism system (*GST*) ([@c40]), lung function (*TLR2, GCR*) ([@c37]), lung cancer ($SAT\alpha$, *NBL2*) ([@c30]), and biological aging ([@c63]).

Despite these findings, no study to date has examined whether the association between long-term air pollution exposure and lung function is mediated by DNA methylation ([@c58]). In this study, we performed a genome-wide methylation study of the long-term air pollution exposure, i.e., $\text{NO}_{2}$ and PM in adults from the LifeLines cohort study. We further investigated to what extent the significant air pollution-associated DNA methylation sites mediated the association between air pollution and lung function.

Methods {#s2}
=======

Study Population and Design {#s2.1}
---------------------------

This study included subjects enrolled in the LifeLines cohort study. LifeLines is a large Dutch population-based cohort study designed to investigate chronic diseases and healthy aging ([@c55]). Detailed information about LifeLines can be obtained at the official website (<http://www.lifelines.net>). The LifeLines cohort study was approved by the Medical Ethical Committee of the University Medical Center Groningen, Groningen, Netherlands. All participants provided written informed consent.

A subgroup of 1,656 subjects of the LifeLines cohort was selected based on having complete data on lung function and specific environmental exposures as well as on covariates used in the analysis: sex, age, height, and smoking history.

Air Pollution Exposure Assessment {#s2.2}
---------------------------------

At the baseline visit (2007--2013), the home addresses of all LifeLines individuals were geocoded and GIS (geographic information system)-derived information on distance to the nearest road, traffic intensity, built-up land, population density, and altitude was acquired. The annual average exposure to $\text{NO}_{2}$, ${PM}_{10}$ (PM with aerodynamic diameter less than $10\mu m$), ${PM}_{2.5}$ (particles with aerodynamic diameter less than $2.5\mu m$) and ${PM}_{2.5\text{absorbance}}$ (indicator of elemental carbon content) ([@c17]) was then estimated using land-use regression models, developed in the ESCAPE study. In these models, the GIS-derived information was combined with annual air pollution concentrations from an intensive monitoring campaign in the ESCAPE study ([@c7]; [@c21]; [@c66]).

Lung Function Assessment {#s2.3}
------------------------

Lung function was measured with spirometry according to standard operating procedures using the Wellch Allyn SpiroPerfect device (Wellch Allyn version 1.6.0.489, personal computer-based SpiroPerfect^™^ with CardioPerfect® Workstation software). $\text{FEV}_{1}$, FVC, $\text{FEV}_{1}/\text{FVC}$, and forced expiratory flow between 25--75% of the FVC ($\text{FEF}_{25–75}$) were used as lung-function outcomes.

Covariate Assessment {#s2.4}
--------------------

Age was calculated based on the date of birth as registered in the municipal registries and the date of the baseline visit. Body mass index (BMI) is calculated as weight divided by height squared, as measured during the baseline visit using standardized procedures. Smoking status and cumulative smoking exposure (pack-years of cigarettes smoked) were assessed using the standardized European Community Respiratory Health Survey (ECRHS) questionnaire ([@c13]). Current smoking was defined as smoking in the last month, and only current smokers with a smoking history greater than five pack-years were included. Never-smokers were defined as having a smoking history of zero pack-years. To optimize the smoking exposure contrast, ex-smokers were not included in this study.

Genome-wide DNA Methylation Assessment {#s2.5}
--------------------------------------

Genome-wide DNA methylation levels were assessed from whole blood of 1,656 subjects using standard methods. Briefly, blood samples were bisulfite-treated (EZ-96 DNA Methylation^™^ Kit; Zymo Research Corp.) and subsequently subjected to whole-genome amplification. DNA methylation level for each CpG site was measured using the Illumina Infinium® Human Methylation 450K array (Illumina, Inc.) and expressed quantitatively as $\beta - \text{value}$. $\beta - \text{Values}$ represent the ratio of the fluorescent signal intensity measured by methylated and unmethylated probes and range from 0 (all copies of the CpG site in the sample are unmethylated) to 1 (all copies of the CpG site in the sample are methylated). Quality control (QC) included removal of samples with probes with a detection $p - \text{value} > 0.01$ in $< 99\%$ of probes, samples with incorrect sex or SNP prediction, as well as probes with a detection $p - \text{value} > 0.01$, sex chromosome probes, probes measuring SNPs, probes where the CpG itself or the single base extension (SBE) site is an SNP, and cross-reactive probes. A total of 420,938 CpG sites passed the QC filtering criteria. The data were normalized using DASEN implemented in the wateRmelon package in R (R Core Team) ([@c50]).

Replication Analysis {#s2.6}
--------------------

Replication of the top CpG sites associated with air pollution exposure was attempted in two independent samples from the population-based Cooperative Health Research in the Region of Augsburg studies \[Kooperative Gesundheitsforschung in der Region Augsburg, Germany (KORA F3 and KORA F4)\]. The KORA F3 examinations took place from 2004 to 2005 ([@c4]; [@c64]), and KORA F4 examinations took place from 2006 to 2008 ([@c52]). For both examinations, health surveys were administered, and biospecimens were collected by trained personnel per published methodologies. Informed consent was provided by all participating individuals. All KORA studies were approved by the ethics committee of the Bavarian Medical Association in Munich, Germany. The KORA F3 and KORA F4 samples used for this replication study were nonoverlapping. Air pollution at the residential address was estimated using land-use regression models as developed in the ESCAPE study ([@c51]). DNA methylation was assessed identically for the KORA F3 and KORA F4 samples. Genome-wide DNA methylation measurement at 485,577 genomic sites was performed using the Infinium® HumanMethylation450K BeadChip (Illumina, Inc.) and expressed quantitatively as $\beta - \text{value}$. The laboratory process has been described previously ([@c65]). To preprocess the DNA methylation data, first, 65 probes that represent SNPs were excluded. Next, background correction using minfi, version 1.6.0 ([@c3]) was performed, and signals represented by fewer than three functional beads were removed. Data were normalized using quantile normalization (QN) on the raw signal intensities ([@c36]). QN was performed on six stratified probe categories based on probe type and color channel ([@c10]) using the R package limma (version 3.16.5; R Core Team). Differences in the signal intensities from Infinium I vs. Infinium II probes designs were corrected using beta-mixture quantile normalization (BMIQ) ([@c59]) via the R package wateRmelon, version 1.0.3 (R Core Team) ([@c50]). White blood cell (i.e., granulocytes, monocytes, B cells, $\text{CD}4 +$ T cells, $\text{CD}8 +$ T cells, and natural killer cells) proportions were estimated using the Houseman method ([@c31]). To keep in concert with the discovery analyses, individuals with a detection $p - \text{value} > 0.05$ for $> 1\%$ of the probes were removed. After quality control, 451 samples were retained in KORA F3 and 1,424 in KORA F4.

Statistical Analyses {#s2.7}
--------------------

Statistical analyses were performed using the SPSS statistics software version 23.0 (IBM) and R software version 3.2.4 revised (R Foundation). Robust linear regression models were used to test the cross-sectional association between air pollution ($\text{NO}_{2}$, ${PM}_{10}$, ${PM}_{2.5}$, and ${PM}_{2.5\text{absorbance}}$) exposure as a predictor and genome-wide DNA methylation levels as a response. The models were adjusted for sex, age, BMI, current smoking, pack-years, and covariates expected to influence the DNA methylation levels (technical covariates and blood cell composition). The potential technical bias was minimized using principal component analysis applied to the control probes included on the 450K chip ([@c36]). We included all PCs that explained $> 1\%$ of the variance. This resulted in the inclusion of the first 7 PCs that together explained 95.5% of total variance. Additionally, the model was adjusted for the measured white blood cell counts (eosinophils, neutrophils, basophils, lymphocytes, and monocytes) to correct for the cellular heterogeneity of blood samples ([@c32]). We used the Bonferroni corrected threshold $p - \text{value} < 1.19 \times 10^{- 7}$ (0.05/420,938) to correct for the number of CpG sites tested. Sites that passed this threshold were considered genome-wide significant and were investigated further in subsequent analyses. To investigate the sensitivity of the results of the analyses between air pollution exposure and methylation to the model specifications we conducted several sensitivity analyses to the top hits of our analyses (see Supplemental Material for details): *a*) exclusion of outliers in the DNA-methylation levels, *b*) additional adjustment for possible confounders (i.e., highest educational level, chronic obstructive pulmonary disease (COPD), asthma, use of respiratory medication), and *c*) stratification of the models by sex, BMI, and smoking. Replication of the top hits was attempted in two independent samples from the KORA study. In this replication analysis, associations were estimated using robust linear regression models and included the following covariates: sex, age, body mass index, current smoking, pack-years, estimated cell counts, and the first 20 PCs from the control probes to adjust for technical variation ([@c36]). As in the discovery analysis, only, never, and current smokers were included in the analysis (ex-smokers were excluded). Significant replication is defined as a $p - \text{value} < 0.05$ in at least one of the replication cohorts, and the direction of the effect should be the same in the discovery and both replication cohorts. In addition, using the software tool provided at <https://129.125.135.180:8080/GeneNetwork/pathway.html>, we conducted a pathway analysis in which we included all genes annotated to CpG sites with an FDR $p - \text{value} < 0.01$, and we investigated the association between our top methylation-sites and gene expression by searching the tables provided at <https://www.genenetwork.nl/biosqtlbrowser/>.

Robust linear regression models adjusted for sex, age, height, BMI, sex\*age interaction, sex\*height interaction, current smoking, and pack-years were used to analyze the cross-sectional association between air pollution exposure and lung function levels, as measured by: $\text{FEV}_{1}$, FVC, $\text{FEV}_{1}/\text{FVC}$, and $\text{FEF}_{25–75}$. Two-sided $p - \text{values} < 0.05$ were considered statistically significant.

The potential mediation by significant air pollution-associated methylation sites was assessed using mediation analysis. By applying the bootstrapping method in the "mediation" package in R (version 4.4.6; R Core Team) ([@c27]), we verified whether the total effect of a specific air pollutant on a lung function outcome was mediated by DNA methylation at the significant CpG sites. To test this mediation effect, two models were applied, and their estimates were used as input for the mediate function ([Figure 1](#f1){ref-type="fig"}). The first model, the mediator model, assessed the effect of air pollution exposure on DNA methylation (association A) and, the second model, the outcome model, assessed the combined effect of air pollution exposure and the mediator (DNA methylation) on a lung function outcome (associations B and C). A total of 1,000 bootstraps were run to estimate the confidence intervals (CIs) ([@c41]). Significant mediation by DNA methylation was considered present when the *p*-value of the average mediation effect (AME) was $< 0.05$. A *p*-value between 0.05 and 0.10 was considered as borderline significant.

![Model showing the associations tested in the mediation analysis. Association A: association between air pollution and DNA methylation; association B: association between DNA methylation and lung function; association C: association between air pollution and lung function with adjustment for DNA methylation.](EHP2045_f1){#f1}

Results {#s3}
=======

Descriptive Statistics {#s3.1}
----------------------

In total, 1,622 subjects passed the quality control of the DNA methylation assessment, and 1,017 subjects had complete data on air pollution exposure, DNA methylation levels, and all included covariates. [Table 1](#t1){ref-type="table"} summarizes the baseline characteristics of the 1,017 subjects with complete data and 605 subjects with incomplete data. The mean age of the complete subjects was 47.3 y, 58% were male, and 56% were never smokers. In current smokers, the mean cumulative smoking exposure was 20.5 pack-years. Mean levels of lung function measured at the baseline visit were: $\text{FEV}_{1}$ $3.5L$ (98% of predicted normal values), FVC $3.5L$ (111% of predicted), $\text{FEV}_{1}/\text{FVC}$ 73.4%, and $\text{FEF}_{25–75}$ 2.8 L/s (70% of predicted) ([@c53]). No significant differences were found between the incomplete and complete subjects. The annual average estimated concentration (range) of exposure was $16.3\,\left( {9.4 - 32.8} \right){\,\mu g/m}^{3}$ for $\text{NO}_{2}$; $24.1\,\left( {23.7 - 27.6} \right){\,\mu g/m}^{3}$ for ${PM}_{10}$; $15.5\,\left( {15.1 - 18.2} \right){\,\mu g/m}^{3}$ for ${PM}_{2.5}$, and $0.9\,\left( {0.8 - 1.6} \right) \times 10^{- 5}m^{- 1}$ for ${PM}_{2.5\text{absorbance}}$. The correlation (Pearson correlation coefficient) among the annual average concentration of pollutants is presented in Supplemental Material (Table S1).

###### 

Characteristics of subjects with incomplete or complete data from the LifeLines Cohort Study.

Table 1 lists characteristics in the first column; the corresponding values for subjects with incomplete data, subjects with complete data, and p-value difference are listed in the other columns.

  Characteristic                                           Incomplete data    Complete data   Difference
  ------------------------------------------------------- ----------------- ----------------- ------------
  *N* (%)                                                    605 (37.3)       1,017 (62.7)     
  Age (y)                                                  $46.8 \pm 10.6$   $47.3 \pm 11.0$  0.38
  Height (cm)                                              $176.4 \pm 9.1$   $177.2 \pm 9.1$  0.08
  BMI (${\text{kg}/{cm}}^{2}$)                             $26.4 \pm 4.1$    $26.0 \pm 3.8$   0.07
  Male                                                       341 (56.4)        587 (57.7)     0.59
  Smoking status                                                                               
  Never smoking                                              343 (56.7)        574 (56.4)     0.92
  Current smoking[^*a*^](#t1n1){ref-type="table-fn"}         262 (43.3)        443 (43.6)     
  Cumulative smoking[^*b*^](#t1n2){ref-type="table-fn"}    $22.0 \pm 11.4$   $20.5 \pm 11.8$  0.09
  Lung function                                                                                
  $\text{FEV}_{1}$ (L)                                      $3.4 \pm 0.9$     $3.5 \pm 0.9$   0.07
  FVC (L)                                                   $4.7 \pm 1.1$     $4.7 \pm 1.1$   0.17
  $\text{FEV}_{1}/\text{FVC}$ (%)                          $72.8 \pm 8.8$    $73.4 \pm 8.6$   0.18
  $\text{FEF}_{25–75}$ (L/s)                                $2.7 \pm 1.3$     $2.8 \pm 1.3$   0.08
  Air pollution                                                                               IQR
  $\text{NO}_{2}$ (${\mu g/m}^{3}$)                              NA          $16.3 \pm 3.2$   4.66
  ${PM}_{10}$ (${\mu g/m}^{3}$)                                  NA          $24.1 \pm 0.5$   0.58
  ${PM}_{2.5}$ (${\mu g/m}^{3}$)                                 NA          $15.5 \pm 0.2$   0.13
  ${PM}_{2.5\text{absorbance}}$ ($10^{- 5}/m$)                   NA           $0.9 \pm 0.1$   0.13

Note: Data are presented as $\text{mean} \pm \text{standard}$ deviation (SD) for continuous variables or *N* (%) for categorical variables; BMI, body mass index; $\text{FEV}_{1}$, forced expiratory volume in 1 second; FCV, forced vital capacity; $\text{FEV}_{1}/\text{FVC}$, forced expiratory volume in 1 sec to forced vital capacity ratio; $\text{FEF}_{25–75}$, forced expiratory flow between 25--75% of the FVC; $\text{NO}_{2}$, nitrogen dioxide; ${PM}_{10}$, particles with aerodynamic diameter $< 10\;\mu m$; ${PM}_{2.5}$, particles with aerodynamic diameter $< 2.5\;\mu m$; ${PM}_{2.5\text{absorbance}}$, indicator of elemental carbon content.

Current smoking is defined as smoking in the last month and only current smokers with a smoking history greater than five pack-years were included.

Cumulative smoking defined by pack-years of cigarettes smoked in current smokers.

Association between Air Pollution Exposure and Genome-Wide DNA Methylation {#s3.2}
--------------------------------------------------------------------------

$\text{NO}_{2}$ exposure was genome-wide significantly associated with differential DNA methylation at seven CpG sites (mapped to seven different genes) at the Bonferroni corrected threshold $p - \text{value} < 1.19 \times 10^{- 7}$ and with 4,980 CpGs at the False Discovery Rate (FDR) $p - \text{value} < 0.05$ ([Table 2](#t2){ref-type="table"}, see also Excel Table S1 and Figure S1). Among these top signals, three CpG sites showed a negative association with $\text{NO}_{2}$ exposure: cg04908668 (*PSMB9*, chr6), cg00344801 (*TTC38*, chr22), and cg02234653 (*AP1S3*, chr2); four showed a positive association: cg14938677 (*ARF5*, chr7), cg18379295 (*GNG2*, chr14), cg25769469 (*PTCD2*, chr5), and cg08500171 (*BAT2*, chr6). The results of the sensitivity analyses on these 7 CpG sites are presented in Tables S2, S3, and S4. Importantly, after removal of outliers in the methylation values 1 CpG (i.e., cg02234653) was no longer significant at the Bonferroni corrected threshold although the effect estimate remained similar (Table S2). None of the genome-wide significant CpG sites associated with $\text{NO}_{2}$ exposure was successfully replicated either in the KORA F3 or in the KORA F4 cohort ([Tables 3](#t3){ref-type="table"} and [4](#t4){ref-type="table"}). The results of the pathway analyses are presented in Excel Tables S2 and S3. A look-up of these 7 CpG sites in the eQTM table provided at <https://www.genenetwork.nl/biosqtlbrowser/> showed that 2 CpGs were associated with gene expression of 3 genes \[i.e., cg04908668 was associated with lower expression of *Proteasome Subunit Beta 9* (*PSMB9*) and of *Transporter 1, ATP Binding Cassette Subfamily B Member* (*TAP1*) genes, and cg00344801 was associated with higher expression of *Tetratricopeptide Repeat Domain 38* (*TTC38*)\] (Table S5). ${PM}_{10}$, ${PM}_{2.5}$, and ${PM}_{2.5\text{absorbance}}$ exposures were not genome-wide significantly associated with DNA methylation, either at the Bonferroni corrected threshold or at the FDR-threshold (see Table S6 and Excel Table S4 and Table S7 for CpG sites associated with a $p - \text{value} < 1 \times 10^{- 5}$). Given that only $\text{NO}_{2}$ exposure was genome-wide significantly associated with DNA methylation, the subsequent mediation analyses were restricted to $\text{NO}_{2}$.

###### 

Genome-wide differential DNA methylation associated with $\text{NO}_{2}$ exposure (per $10{\,\mu g/m}^{3}$ ) in the LifeLines Cohort Study ($n = 1,017$).

Table 2 lists CpG sites in the first column; the corresponding values of B (effect estimate) plus or minus SE (standard error), p values, chromosome, Bp position, gene, location in gene, and relation to island are listed in the other columns.

  CpG site     $B \pm \text{SE}$[^*a*^](#t2n1){ref-type="table-fn"}   *p*-Value[^*b*^](#t2n1){ref-type="table-fn"}   Chr   Bp position   Gene    Location in gene   Relation to island
  ------------ ------------------------------------------------------ ---------------------------------------------- ----- ------------- ------- ------------------ --------------------
  cg04908668   $- 0.012 \pm 0.002$                                    $7.94 \times 10^{- 9}$                         6     32823941      PSMB9   Body               S_Shore
  cg14938677   $0.023 \pm 0.004$                                      $1.05 \times 10^{- 8}$                         7     127231698     ARF5    3\'UTR             S_Shelf
  cg00344801   $- 0.028 \pm 0.005$                                    $2.38 \times 10^{- 8}$                         22    46685728      TTC38   Body               Island
  cg18379295   $0.020 \pm 0.004$                                      $3.50 \times 10^{- 8}$                         14    52326155      GNG2    TSS1500            OpenSea
  cg25769469   $0.035 \pm 0.006$                                      $3.69 \times 10^{- 8}$                         5     71643841      PTCD2   Body               OpenSea
  cg02234653   $- 0.017 \pm 0.003$                                    $4.07 \times 10^{- 8}$                         2     224625080     AP1S3   Body               OpenSea
  cg08500171   $0.023 \pm 0.004$                                      $9.81 \times 10^{- 8}$                         6     31590674      BAT2    Body               S_Shore

Effect $\text{estimates} \pm \text{standard}$ error (SE) of DNA methylation per $10 - {\mu g/m}^{3}$ increase in $\text{NO}_{2}$ concentration adjusted for sex, age, BMI, current smoking, pack-years, technical variance, and blood cell composition. Chr, chromosome.

Bonferroni corrected threshold $p - \text{value} < 1.19 \times 10^{- 7}$.

###### 

Characteristics of the subjects included in the discovery and replication analyses.

Table 3 lists characteristics in the first column; the corresponding values for discovery cohort and replication cohorts KORA F3 and KORA F4 are listed in the other columns.

  Characteristic                                           Discovery cohort   Replication cohorts  
  ------------------------------------------------------- ------------------ --------------------- -----------------
  *N*                                                           1,017                 422                 971
  Age (y)                                                  $47.3 \pm 11.0$      $53.2 \pm 9.6$      $60.9 \pm 8.8$
  BMI (${\text{kg}/{cm}}^{2}$)                              $26.0 \pm 3.8$      $27.1 \pm 4.4$      $27.8 \pm 4.6$
  Male                                                        587 (57.7)          261 (51.2)          383 (39.4)
  Smoking status                                                                                            
  Never smoking                                               574 (56.4)          205 (48.6)          721 (74.3)
  Current smoking[^*a*^](#t3n1){ref-type="table-fn"}          443 (43.6)          217 (51.4)          250 (25.7)
  Cumulative smoking[^*b*^](#t3n1){ref-type="table-fn"}    $20.5 \pm 11.8$      $26.2 \pm 20.6$     $30.6 \pm 24.4$
  Air pollution                                                                                             
  $\text{NO}_{2}$ (${\mu g/m}^{3}$)                         $16.3 \pm 3.2$      $18.3 \pm 3.7$      $18.8 \pm 3.9$

Note: Data are presented as $\text{mean} \pm {standard}$ deviation (SD) for continuous variables or *N* (%) for categorical variables. BMI, body mass index; $\text{NO}_{2}$, nitrogen dioxide.

Current smoking is defined as smoking in the last month and only current smokers with a smoking history greater than five pack-years were included.

Cumulative smoking defined by pack-years of cigarettes smoked in current smokers.

###### 

Replication analysis: robust linear regression analysis for the association between $\text{NO}_{2}$ and DNA methylation at the 7 genome-wide significant CpG sites in the KORA F3 and F4 cohort.

Table 4 lists CpG sites in the first column; the corresponding B values, standard error, and p values for discovery cohort (n equals 1017), KORA F3 (n equals 422), and KORA F4 (n equals 971) are listed in the other columns.

  CpG          Discovery cohort ($n = 1,017$)   KORA F3 ($n = 422$)   KORA F4 ($n = 971$)                                                      
  ------------ -------------------------------- --------------------- ------------------------ ----------- ------- ------- ----------- ------- -------
  cg04908668   $- 0.012$                        0.002                 $7.94 \times 10^{- 9}$   $- 0.002$   0.002   0.260   0.000       0.002   0.446
  cg14938677   0.023                            0.004                 $1.05 \times 10^{- 8}$   $- 0.008$   0.003   0.013   0.001       0.003   0.394
  cg00344801   $- 0.028$                        0.005                 $2.38 \times 10^{- 8}$   $- 0.002$   0.004   0.258   $- 0.001$   0.003   0.421
  cg18379295   0.020                            0.004                 $3.50 \times 10^{- 8}$   $- 0.004$   0.004   0.147   $- 0.002$   0.003   0.233
  cg25769469   0.035                            0.006                 $3.69 \times 10^{- 8}$   0.003       0.006   0.292   $- 0.008$   0.005   0.056
  cg02234653   $- 0.017$                        0.003                 $4.07 \times 10^{- 8}$   0.003       0.003   0.198   $- 0.002$   0.002   0.149
  cg08500171   0.023                            0.004                 $9.81 \times 10^{- 8}$   $- 0.003$   0.004   0.202   $- 0.002$   0.003   0.269

Note: Effect estimate per $10 - {\mu g/m}^{3}$ increase in $\text{NO}_{2}$ concentration. Robust linear regression analysis adjusted for sex, age, BMI, current smoking, pack-years, technical variance. and blood cell composition.

Association between Air Pollution Exposure and Lung Function {#s3.3}
------------------------------------------------------------

[Table 5](#t5){ref-type="table"} shows the association between $\text{NO}_{2}$ exposure and lung function levels (see Table S8 for the associations between all pollutants and lung function). $\text{NO}_{2}$ exposure was borderline significantly associated with FVC ($B$ per $10{\,\mu g/m}^{3}$ $\text{NO}_{2} = - 106.3$, 95% $\text{CI} = - 219.1 - 6.6$, $p = 0.065$) and with $\text{FEV}_{1}/\text{FVC}$ ($B = 1.5$, 95% $\text{CI} = - 0.1 - 3.0$, $p = 0.060$). $\text{FEV}_{1}$ was not significantly associated with $\text{NO}_{2}$ exposure, indicating that the positive association between $\text{NO}_{2}$ and $\text{FEV}_{1}/\text{FVC}$ is driven by a stronger negative association with FVC than $\text{FEV}_{1}$. Given that $\text{NO}_{2}$ exposure was associated with FVC and with $\text{FEV}_{1}/\text{FVC}$, we examined the mediation by DNA methylation for $\text{FEV}_{1}$, FVC and $\text{FEV}_{1}/\text{FVC}$.

###### 

Effect estimates of $\text{NO}_{2}$ exposure on lung function ($\text{FEV}_{1}$ , FVC, $\text{FEV}_{1}/\text{FVC}$ and $\text{FEF}_{25–75}$) for 1,017 subjects enrolled in the LifeLines Cohort Study.

Table 5 lists variables in the first column; the corresponding B values (95 percent confidence intervals) and p values for nitrogen dioxide are listed in the other columns.

  Variable                                                             $\text{NO}_{2}$              
  -------------------------------------------------------------------- ---------------------------- -------
  $\text{FEV}_{1}$ (mL)[^*b*^](#t5n2){ref-type="table-fn"}             2.4 ($- 94.8$, 99.6)         0.962
  FVC (mL)[^*b*^](#t5n2){ref-type="table-fn"}                          $- 106.3$ ($- 219.1$, 6.6)   0.065
  $\text{FEV}_{1}/\text{FVC}$ (%)[^*c*^](#t5n3){ref-type="table-fn"}   1.5 ($- 0.1$, 3.0)           0.06
  $\text{FEF}_{25–75}$ (mL/s)[^*d*^](#t5n4){ref-type="table-fn"}       128.5 ($- 69.8$, 326.8)      0.204

Effect estimates and 95% confidence interval (95% CI) for $\text{NO}_{2}$ are given per $10 - {\mu g/m}^{3}$ increase.

For $\text{FEV}_{1}$ and FVC, robust regression analysis adjusted for sex, age, height, BMI, sex\*age interaction, sex\*height interaction, current-smoking, and pack-years.

For $\text{FEV}_{1}/\text{FVC}$, robust regression analysis adjusted for sex, age, BMI, sex\*age interaction, current-smoking, and pack-years.

For $\text{FEF}_{25–75}$, robust regression analysis adjusted for sex, age, height, BMI, sex\*age interaction, sex\*height interaction, current-smoking, pack-years, and FVC.

Mediation Analysis {#s3.4}
------------------

Mediation analysis showed that one of the seven top CpG sites significantly mediated the association between $\text{NO}_{2}$ exposure and FVC (cg14938677), and 2 CpG sites significantly mediated the association between $\text{NO}_{2}$ and $\text{FEV}_{1}/\text{FVC}$ (cg14938677 and cg18379295) (Table S9).

Discussion {#s4}
==========

We performed a cross-sectional genome-wide methylation study in blood to investigate whether long-term air pollution exposure is associated with DNA methylation in the LifeLines cohort study. We further investigated whether the association between air pollution exposure and lung function was mediated by DNA methylation. In our genome-wide methylation study, we identified differential DNA methylation at seven CpG sites to be genome-wide significantly associated with $\text{NO}_{2}$ exposure. After removal of outliers in the methylation values, six CpG sites remained significantly associated with $\text{NO}_{2}$ levels. Unfortunately, none of these associations could be significantly replicated in two independent cohorts. Further, higher levels of $\text{NO}_{2}$ exposure were borderline significantly associated with lower FVC and higher $\text{FEV}_{1}/\text{FVC}$ levels. Finally, we found one out of seven CpG sites (cg14938677 in *ARF5*) was a significant mediator between $\text{NO}_{2}$ exposure and FVC, and two CpG sites (cg14938677 in *ARF5* and cg18379295 in *GNG2*) were significant mediators of the association between $\text{NO}_{2}$ exposure and $\text{FEV}_{1}/\text{FVC}$.

The top-significant CpG site (cg04908668) identified in our genome-wide methylation study on $\text{NO}_{2}$ maps to *PSMB9* (chromosome 6) and is associated with lower gene expression of *PSMB9* and *TAP1* (<https://www.genenetwork.nl/biosqtlbrowser>). *PSMB9* and *TAP1* are suggested to be involved in the pathophysiological mechanisms underlying COPD. Fujino et al. ([@c23]) report both *PSMB9* and *TAP1* to be differentially expressed in alveolar epithelial type II cells isolated from COPD patients, in comparison with healthy subjects. The putative function of all genes identified in our study is presented in the Supplemental Material (Table S10). Interestingly, 2 of the 7 genome-wide significant CpG sites (i.e., cg14938677 and cg00344801) were also described by Joehanes et al. ([@c34]) in relation to smoking habits, which might indicate they are general markers of inhaled particle exposure.

To date, genome-wide DNA methylation analyses of $\text{NO}_{2}$ allowing a hypothesis-free assessment of epigenetic modifications are scarce. However, relevant evidence comes from a study in children by Gruzieva et al. ([@c26]). In this epigenome-wide meta-analysis of methylation, prenatal $\text{NO}_{2}$ exposure was associated with differential DNA methylation of genes involved in mitochondria and antioxidant defense pathways. Interestingly, in our genome-wide methylation study on $\text{NO}_{2}$, we also identified a CpG (cg25769469) in *PTCD2* that is reported to be involved in the mitochondrial RNA metabolism.

The positive association between $\text{NO}_{2}$ exposure and $\text{FEV}_{1}/\text{FVC}$ found in our study is in line with findings reported in a larger sample of the LifeLines cohort ($n = 51,855$ subjects) ([@c18]). In this larger sample, $\text{NO}_{2}$ had a stronger negative association with FVC than with $\text{FEV}_{1}$ resulting in a higher $\text{FEV}_{1}/\text{FVC}$. In our current smaller sample, the lack of significant association between $\text{NO}_{2}$ and $\text{FEV}_{1}$ may be the result of low study power (due to smaller sample size and smaller air pollution ranges). $\text{FEV}_{1}$ and FVC are considered early indicators of chronic respiratory disease and predictors for cardiorespiratory mortality ([@c35]). Clinically, a reduced FVC along with $\text{FEV}_{1}$ within a normal range is indicative (but not specific) of restrictive ventilatory abnormalities ([@c48]). A comparison with existing studies shows that this restrictive effect is not universally seen. For example, in the ESCAPE study, the negative association between $\text{NO}_{2}$ exposure and $\text{FEV}_{1}$ and FVC are of equal magnitude ([@c2]). Because the main parameter for the diagnosis of restriction is a low total lung capacity (TLC), further studies including TLC are warranted to better elucidate whether the observed ventilatory pattern associated with $\text{NO}_{2}$ exposure corresponds to a restrictive, obstructive or both types of disorders.

We tested mediation by DNA methylation to confirm our hypothesis that $\text{NO}_{2}$ exposure may affect lung function through effects on DNA methylation. Among the seven differentially methylated CpG sites, two showed suggestive evidence for mediation (cg14938677 in *ARF5* and cg18379295 in *GNG2*). *ARF5* is a member of the human ADP-ribosylation factor (ARF) gene family that encodes small guanine nucleotide binding proteins. These proteins activate the phospholipase D (PLD), a critical enzyme involved in various endothelial and epithelial cell functions, such as actin cytoskeleton, vesicle trafficking for secretion, and endocytosis and receptor signaling ([@c33]). A family member, PLA1, was found to be significantly increased in plasma membrane of $\text{NO}_{2} - \text{exposed}$ pulmonary artery endothelial cells ([@c9]; [@c56]). Furthermore, the redox regulation of bleomycin-induced PLD activation was reported to play a crucial role in the cytotoxicity underlying the idiopathic pulmonary fibrosis ([@c47]). The *GNG2* (G protein subunit gamma 2) gene belongs to the heterotrimeric G protein family that underlies important pathways involved in cell migration, proliferation, differentiation, apoptosis, and responses to external signals ([@c45]). Its distinct isoform subunits $\alpha$, $\beta$, and $\gamma$ are selectively expressed and enriched in different tissues including white blood cells and lung ([@c42]). To date, we do not know whether differential DNA methylation at this particular CpG site (cg18379295), located in the transcription start site of the gene, results in any functional variation in lung function. However, *GNG2* was reported to be involved in airway hyper-responsiveness and inflammation elicited by an antigen challenge in a rabbit model of asthma ([@c43]). Furthermore, upon activation by G protein-coupled receptors (GPCRs), both free $G\alpha$ and $G\beta\gamma$ subunits regulate important signaling pathways like the MAPK kinase cascade. This MAPK kinase cascade is involved in various immune and inflammatory cell functions and is a plausible mechanism linking air pollution exposure and respiratory and cardiovascular outcomes ([@c14]).

A large number of studies have linked short- and mid-term PM exposure to global and gene-specific DNA methylation ([@c5]; [@c8]; [@c15]; [@c49]; [@c62]). A genome-wide meta-analysis of DNA methylation and ${PM}_{2.5}$ identified twelve genes regulating pathways involved in tumor development, inflammatory stimuli, pulmonary disorders and glucose metabolism ([@c46]). However, few studies have examined this association in the context of a long-term exposure window ([@c16]; [@c63]). Although we found no genome-wide significant effect of PM exposure (considering all different size fractions) on DNA methylation, many CpG sites had suggestive effects, especially in response to ${PM}_{2.5}$ (Table S8). Possibly, the relatively small range of PM levels and consequently a modest exposure contrast in LifeLines cohort may explain this lack of association. Future genome-wide methylation studies conducted in cohorts with a broader range of PM exposure is needed to clarify this association.

Our study is the largest genome-wide methylation study of air pollution exposure in adults, and the first study to assess the mediation effect of DNA methylation in the association between air pollution and the $\text{FEV}_{1}/\text{FVC}$ ratio. However, this study has some limitations. We used the individual's home address as basis for the air pollution exposure estimates, ignoring the fact that a person could spend time in another environment (e.g., while traveling or working), which might lead to some degree of exposure misclassification at the individual level ([@c57]). Interestingly, this exposure misclassification may lead to overestimation of the mediation effect ([@c61]) when the methylation levels at our identified CpG sites are better biomarkers of personal $\text{NO}_{2}$ exposure than the estimated $\text{NO}_{2}$ exposure using land-use-regression models. The results of the mediation analyses should thus be interpreted with caution. In addition, because our study was cross-sectional in design, the inference of causality from these measures could be questionable.

We also recognize that ambient air pollution is a complex mixture and the effects attributed to some specific component might be influenced by the underlying toxicity of the full mixture of all pollutants. In this study, we estimated the association between various pollutants and DNA methylation, but only found genome-wide significant associations with $\text{NO}_{2}$. The moderate to high correlation between $\text{NO}_{2}$ and other pollutants prohibits the use of multipollutant models, and thus we cannot completely disentangle the independent pollutant effect. However, the top CpG sites differ for the different pollutants, indicating that each pollutant may have its own specific methylation target sites.

Another potential limitation of this study is the use of DNA methylation in blood samples when the outcome of interest is lung function. To what extent these epigenetic changes that we observe in peripheral blood cells reflect changes in DNA methylation in target tissues like the lung merits further investigation. Finally, the identified associations between $\text{NO}_{2}$ exposure and DNA methylation did not replicate in two independent cohorts from the German KORA study. This lack of replication could be explained by the differences in age, gender, BMI, and smoking habits between the cohorts (see [Table 3](#t3){ref-type="table"}), and therefore more replication studies should be performed to validate these findings.

Conclusions {#s5}
===========

In the largest genome-wide methylation study to date, long-term $\text{NO}_{2}$ exposure was associated with differential DNA methylation in blood in 1,017 subjects from the LifeLines cohort study. Among the significant $\text{NO}_{2} - \text{associated}$ DNA methylation sites, 2 CpGs can be considered potential mediators of the association between $\text{NO}_{2}$ exposure and lung function. In this perspective, replication of these findings in other cohorts is necessary to elucidate the suggested role of epigenetic variability in the pathogenesis of $\text{NO}_{2} - \text{exposure}$-related respiratory disease.
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